Prosexual drugs: Empirical status of the "new aphrodisiacs"

Archives of Sexual Behavior

Volumn 22, Issue 6, 1993, Pages 521-543

  Rosen, Raymond C ^a   Ashton, Adam Keller ^b  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

aphrodisiac; apomorphine; neurotransmitter; pharmacology; prosexual drug; yohimbine

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; AFRODODEX; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMFEBUTAMONE; APHRODISIAC AGENT; APOMORPHINE; BETHANECHOL; BUSPIRONE; CARBACHOL; CHOLINERGIC RECEPTOR STIMULATING AGENT; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; FENFLURAMINE; LEVODOPA; NEFAZODONE; NEUROPEPTIDE; NEUROTRANSMITTER; NOMIFENSINE; NORADRENALIN; OXOTREMORINE; PERGOLIDE MESILATE; SEROTONIN; SEROTONIN ANTAGONIST; TRAZODONE; UNCLASSIFIED DRUG; YOHIMBINE;

CARDIOVASCULAR DISEASE; DOPAMINERGIC SYSTEM; DROWSINESS; DRUG EFFECT; GASTROINTESTINAL SYMPTOM; HUMAN; NEUROTOXICITY; NEUROTRANSMISSION; NORADRENERGIC SYSTEM; PENIS ERECTION; PRIAPISM; PRIORITY JOURNAL; REVIEW; SEROTONINERGIC SYSTEM; SEXUAL AROUSAL; SEXUAL DYSFUNCTION;

APHRODISIACS; BETHANECHOL; BETHANECHOL COMPOUNDS; DOPAMINE AGENTS; FEMALE; FENFLURAMINE; HUMAN; MALE; SEX BEHAVIOR; SEX DISORDERS; TRAZODONE; YOHIMBINE;

EID: 0027373594     PISSN: 00040002     EISSN: 15732800     Source Type: Journal    
DOI: 10.1007/BF01543299     Document Type: Article

References (91)

1. GABA-ergic drugs and sexual behavior in the male rat
2. Effects of stereoselective 5-HT-1A agonists on male rat sexual behavior
3. Clinical effects of amphetamine and L-dopa on sexuality and aggression
4. Sexual dysfunction in hypertensive men: A critical review of the literature
5. Analysis of factors involved in the arousol, maintenance, and manifestation of sexual excitement in male animals
6. Effect of L-dopa on sexually impotent patients
7. Pharmacological analysis of male rat sexual behavior
8. Sexual behavior during L-dopa treatment for Parkinsonism
9. Sexual function and affect in Parkinson men treated with L-dopa
10. Sexual function in patients with Parkinson's disease and their partners
11. Pharmacosexology: The effects of drugs on sexual function
12. Substance abuse and high-risk sexual behavior
13. Effects of androgen treatment in impotent men with normal and low levels of free testosterone
14. Apomorphine, deprenyl, and yohimbine fail to increase sexual behavior in rhesus males
15. Enhancement of sexual motivation in male rats by yohimbine
16. Evidence for the modulation of sexual behavior by alpha-adrenoceptors in male rats
17. Pharmacologic modification of psychosexual dysfunction
18. Alcohol and human sexuality: Review and integration
19. Assessment of erectogenci properties of apomorphine and yohimbine in man
20. Neuropeptides and male sexual behavior
21. Sexual motivation: A neural and behavioral analysis of the mechanisms underlying appetitive and copulatory responses of male rats
22. Of rats and men: The comparative approach to male sexuality
23. The role of the 5-HT-2 receptor in the regulation of sexual performance of male rats
24. Approaches for the development of oral drug therapies for erectile dysfunction
25. Increased sexual function with nomifensine
26. Increased libido in women receiving trazodone
27. Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients
28. Reversal by bethanechol of sexual dysfunction caused by anticholinergic antidepressants
29. Fluoxetine-induced sexual dysfunction
30. Intracerebral infusions of oxotremorine affect male sex behavior
31. Dopaminergic control of male sexual behavior in rats: Effects of an intracerebrally-infused agonist
32. Is L-dopa an aphrodisiac in patients with Parkinson's disease?
33. The activating effect of L-dopa treatment on sexual functions and its experimental background
34. Pergolide therapy in Parkinson's disease
35. Sexual experience and drinking among women in a U.S. national survey
36. Fluoxetine and anorgasmia
37. CNS effects of centrally-active antihypertensive agents: A prospective, placebo-controlled study of sleep, mood state, cognitive and sexual function in hypertensive males
38. Differential interactions of “prosexual” drugs with 5-hydroxytryptamine1A and alpha-2 adrenergic receptors
39. Effects of apomorphine, a dopamine receptor against, on penile tumescence in normal subjects
40. Apomorphine induced penile tumescence in impotent patients—preliminary findings
41. Treatment of impotence with trazodone: A case report
42. Apomorphine: Clinical studies on erectile impotence and yawning
43. Effects of intrathecal administration of 8-OH-DPAT on genital reflexes and mating behavior in male rats
44. Statistical summary of 10,000 male cases using afrodex in the treatment of impotence
45. Unusual side effects of clomipramine associated with yawning
46. Repeated observations of yawning, clitoral engorgement, and orgasm associated with fluoxetine administration
47. Anorgasmia from clomipramine in obsessive-compulsive disorder: A controlled trial
48. Is yohimbine effective in the treatment of organic impotence? Results of a controlled trial
49. Yohimbine for treatment of impotence in diabetes
50. Effect of buspirone on sexual dysfunction in patients with generalized anxiety disorder
51. Opioids and sexual behavior
52. Differential effects of dopamine receptor antagonists in sexual behavior of male rats
53. Subjective costs of antihypertensive treatment
54. Dexfenfluramine neurotoxicity in brains of nonhuman primates
55. Alcohol and drug effects on sexual response: Human experimental and clinical studies
56. Antidopaminergic properties of yohimbine
57. Trazodone and priapism
58. Chronic alcoholism and male sexual dysfunction
59. Treatment of alcoholism using Dent oral apomorphine method
60. Reversal by bethanacol of impramine-induced ejaculatory dysfunction
61. Effects of psychotropic drugs on human erection and ejaculation
62. Sexual dysfunction with antihypertensive and antipsychotic agents
63. An evaluation of Afrodex in the management of male impotency: A double-blind crossover study
64. The role of yohimbine for the treatment of erectile impotence
65. Anti-depressant induced sexual dysfunction in men: Due to cholinergic blockade?
66. Neural control of penile erection
67. Effects of m-chlorophenyl-piperazine on penile and bladder function in rats
68. The aphrodisiac effect of fenfluramine: Two case reports of a possible side effect to the use
69. Increased libido in three men treated with Trazodone
70. Effect of yohimbine hydrochloride on erectile impotence: A double-blind study
71. The control of deviant sexual behavior by drugs: A double-blind controlled study of benperidol, chlorpromazine, and placebo
72. Historical, scientific, clinical and feminist criticisms of “the human sexual response cycle” model
73. Hypersensitivity with antiparkinsonian therapy
74. Trazodone and priapism
75. Trazadone: Its effects on nocturnal penile tumescence
76. The effects of nefazodone, trazodone, buspirone, and placebo on sleep and sleep related penile erections (NPT) in normal subjects
77. The effects of alcohol on human sexual behavior
78. Bethanechol chloride can reverse erectile and ejaculatory dysfunction induced by tricyclic antidepressants and mazindol: Case report